戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 childhood bacteremia, with a predominance of Salmonella enterica serovar Typhi.
2 e systemic infection caused by the bacterium Salmonella enterica serovar Typhi.
3 le to typhoid fever caused by infection with Salmonella enterica serovar Typhi.
4 ical isolate of the human-specific pathogen, Salmonella enterica serovar Typhi.
5 ified that target the Vi capsular antigen of Salmonella enterica serovar Typhi.
6 exhibit specificity for Vi capsule producing Salmonella enterica serovar Typhi.
7 nts likely explains the monophasic nature of Salmonella enterica serovar Typhi.
8 Y. pestis and the exclusively human pathogen Salmonella enterica serovar Typhi.
9 uncharacterized proteins encoded by genes of Salmonella enterica serovar Typhi and E. coli O157:H7 (i
10 of a chromosomal region designated SPI-10 in Salmonella enterica serovar Typhi and located adjacent t
11 man monocyte-derived macrophages (MDMs) with Salmonella enterica serovar Typhi and S. Typhimurium wil
12 a human-specific serovar that, together with Salmonella enterica serovar Typhi and Salmonella enteric
13                                              Salmonella enterica serovar Typhi and Typhimurium vaccin
14                                              Salmonella enterica serovars Typhi and Paratyphi A cause
15        The burden of enteric fever caused by Salmonella enterica serovars Typhi and Paratyphi is subs
16 tion caused by ingestion of human-restricted Salmonella enterica serovars Typhi and Paratyphi predomi
17               We investigated the ability of Salmonella enterica serovars Typhi and Typhimurium to mu
18 p., Rickettsia spp., Salmonella enterica and Salmonella enterica serovar Typhi, and Yersinia pestis),
19 e used a protein microarray containing 2,724 Salmonella enterica serovar Typhi antigens (>63% of prot
20                        Although SPI-7 within Salmonella enterica serovar Typhi appears to be fixed wi
21                              CFTR is used by Salmonella enterica serovar Typhi as a receptor on epith
22 n humans, including Mycobacterium leprae and Salmonella enterica serovar Typhi, but the function of p
23 ay an important role in host defense against Salmonella enterica serovar Typhi by several effector me
24                                              Salmonella enterica serovar Typhi can colonize the gallb
25                                              Salmonella enterica serovar Typhi can establish a chroni
26 serovars, which cause self-limiting disease, Salmonella enterica serovar Typhi can infect only humans
27                          Human infections by Salmonella enterica serovar Typhi can lead to typhoid fe
28 e that the causative agent of typhoid fever, Salmonella enterica serovar Typhi, can partially subvert
29                                              Salmonella enterica serovar Typhi causes an estimated 22
30                                              Salmonella enterica serovar Typhi causes the systemic di
31 ally encoded 34-kDa cytolysin A hemolysin of Salmonella enterica serovar Typhi (ClyA) as a novel expo
32                                          The Salmonella enterica serovar Typhi CT18 (S.Typhi) chromos
33 e applied the IVOM approach to the genome of Salmonella enterica serovar Typhi CT18, a well-studied p
34 li O157:H7 Sakai, Haemophilus influenzae Rd, Salmonella enterica serovar Typhi CT18, and two strains
35 fective in young infants, we used attenuated Salmonella enterica serovar Typhi CVD 908-htrA and Shige
36 d in mice immunized intranasally either with Salmonella enterica serovar Typhi CVD 908-htrA or Shigel
37                            We show here that Salmonella enterica serovar Typhi encodes CDT activity,
38                                   Attenuated Salmonella enterica serovar Typhi has been studied as an
39                       Multiyear epidemics of Salmonella enterica serovar Typhi have been reported fro
40                                              Salmonella enterica serovar Typhi (hereafter referred to
41 tic treatments are often ineffectual against Salmonella enterica serovar Typhi in carriers with galls
42 ent in the Indian subcontinent, with chronic Salmonella enterica serovar Typhi infection reported as
43 city, even though their role in clearance of Salmonella enterica serovar Typhi infections is poorly d
44 ptor for entry of Pseudomonas aeruginosa and Salmonella enterica serovar Typhi into epithelial cells.
45                                              Salmonella enterica serovar Typhi is a human host-adapte
46                                              Salmonella enterica serovar Typhi is a human-restricted
47                                              Salmonella enterica serovar Typhi is associated with a d
48                                              Salmonella enterica serovar Typhi is the etiological age
49                     Enteric fever, caused by Salmonella enterica serovar Typhi, is an important publi
50        We report a typhoid fever case with a Salmonella enterica serovar Typhi isolate showing extend
51                          Finally, attenuated Salmonella enterica serovar Typhi live vaccine vector ca
52                                   Attenuated Salmonella enterica serovar Typhi live vector vaccine st
53   The asymptomatic, chronic carrier state of Salmonella enterica serovar Typhi occurs in the bile-ric
54 lly and results from systemic infection with Salmonella enterica serovar Typhi or Paratyphi pathovars
55      Disappointingly, several new attenuated Salmonella enterica serovar Typhi oral vaccines (e.g., C
56 ll-characterized structures: SPI-7, found in Salmonella enterica serovar Typhi; PAP1 or pKLC102, foun
57    PCR methodology was developed to identify Salmonella enterica serovars Typhi, Paratyphi A, and Par
58 ivalent to fever (39 degrees C-42 degrees C) Salmonella enterica serovars Typhi, Paratyphi A, and Sen
59        In areas of Asia, multidrug-resistant Salmonella enterica serovar Typhi (S Typhi) has been the
60 ting protein, to influence susceptibility to Salmonella enterica serovar Typhi (S Typhi) infection.
61                                              Salmonella enterica serovar Typhi (S Typhi) is responsib
62 revious studies in volunteers immunized with Salmonella enterica serovar Typhi (S.
63                                              Salmonella enterica serovar Typhi (S. Typhi) differs fro
64 Here whole-genome sequence analysis of 1,832 Salmonella enterica serovar Typhi (S. Typhi) identifies
65                                              Salmonella enterica serovar Typhi (S. typhi) is a human-
66                                              Salmonella enterica serovar Typhi (S. typhi) is the aeti
67       We evaluated whether immunization with Salmonella enterica serovar Typhi (S. Typhi) strain CVD
68                                              Salmonella enterica serovar Typhi (S. typhi) strain Ty21
69                                              Salmonella enterica serovar Typhi (S. Typhi), the aetiol
70                            The population of Salmonella enterica serovar Typhi (S. Typhi), the causat
71 is exclusively encoded by the human-specific Salmonella enterica serovars Typhi (S. Typhi) and Paraty
72                                              Salmonella enterica serovar Typhi (Salmonella Typhi) cau
73                  Ninety-three percent of the Salmonella enterica serovar Typhi samples isolated were
74 roteins of the Vi capsular polysaccharide of Salmonella enterica serovar Typhi (serovar Typhi) are en
75                                              Salmonella enterica serovar Typhi strain CVD 908-htrA is
76               Here we used a live attenuated Salmonella enterica serovar Typhi strain to create a biv
77 esent the 4.8-Mb complete genome sequence of Salmonella enterica serovar Typhi strain Ty2, a human-sp
78  a deletion in the guaBA locus of pathogenic Salmonella enterica serovar Typhi strain Ty2.
79 ed into the licensed typhoid vaccine strain, Salmonella enterica serovar Typhi strain Ty21a, and was
80 esized that adequately engineered attenuated Salmonella enterica serovar Typhi strains can serve as m
81  investigated the ability of live attenuated Salmonella enterica serovar Typhi strains delivered to m
82                                          Two Salmonella enterica serovar Typhi strains that express a
83                                              Salmonella enterica serovar Typhi, the causative agent o
84                                              Salmonella enterica serovar Typhi, the cause of typhoid
85 oteins expressed during human infection with Salmonella enterica serovar Typhi, the cause of typhoid
86                                              Salmonella enterica serovar Typhi, the cause of typhoid,
87 tor on gastrointestinal epithelial cells for Salmonella enterica serovar Typhi, the etiologic agent o
88  Salmonella enterica serovar Paratyphi A and Salmonella enterica serovar Typhi to induce protective i
89 lial receptor mediating the translocation of Salmonella enterica serovar Typhi to the gastric submuco
90                                     M01ZH09 (Salmonella enterica serovar Typhi [Ty2 aroC(-) ssaV(-)]
91                                  Isolates of Salmonella enterica serovar Typhi (Typhi), a human-restr
92 osa, nontypeable Haemophilus influenzae, and Salmonella enterica serovar Typhi/Typhimurium.
93                                              Salmonella enterica serovar Typhi vaccine strain CVD 908
94 ive of this study was to enhance survival of Salmonella enterica serovar Typhi vaccine strains at pHs
95                     The biofilms formed by a Salmonella enterica serovar Typhi Vi antigen mutant, as
96 ded-spectrum-beta-lactamase (ESBL)-producing Salmonella enterica serovar Typhi was identified, whole-
97 the serotyped salmonellae, 14% (21/152) were Salmonella enterica serovar Typhi, whereas 86% (131/152)

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。